|
|
|
|
LEADER |
01901nam a22002655i 4500 |
001 |
000291237 |
005 |
20210915152627.0 |
007 |
cr nn 008mamaa |
008 |
150317s2015 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781493925537
|
024 |
7 |
|
|a 10.1007/978-1-4939-2553-7
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
100 |
1 |
|
|a Jain, Kewal K.
|e author.
|
245 |
1 |
0 |
|a Textbook of Personalized Medicine /
|c by Kewal K. Jain.
|
250 |
|
|
|a 2nd ed. 2015.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Humana,
|c 2015.
|
300 |
|
|
|a XL, 732 p. 31 illus. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Basic Aspects -- Molecular Diagnostics in Personalized Medicine -- Role of Biomarkers in Personalized Medicine -- Pharmacogenetics -- Pharmacogenomics -- Pharmacoproteomics.- Role of Metabolomics in Personalized Medicine -- Non-genomic Factors in the Development of Personalized Medicine -- Personalized Biological Therapies -- Personalized Therapy of Cancer -- Personalized Management of Infectious Diseases -- Personalized Management of Neurological Disorders -- Personalized Management of Psychiatric Disorders -- Personalized Management of Cardiovascular Disorders -- Personalized Management of Pulmonary Disorders -- Personalized Management of Genetic Disorders -- Personalized Approaches to Immune Disorders -- Personalized Approaches to Miscellaneous Problems in Healthcare.- Personalized Non-Pharmacological Therapies -- Development of Personalized Medicine.- Ethical Aspects of Personalized Medicine -- Regulatory Aspects of Personalized Medicine.- Economics of Personalized Medicine -- Future of Personalized Medicine.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|